← Back to Clinical Trials
Recruiting NCT06404632

NCT06404632 A Group Intervention for Promoting Health-related Habits (LEV-G)

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06404632
Status Recruiting
Phase
Sponsor Region Stockholm
Condition Life Style
Study Type INTERVENTIONAL
Enrollment 30 participants
Start Date 2024-04-12
Primary Completion 2027-02-28

Eligibility & Interventions

Sex All sexes
Min Age 15 Years
Max Age 80 Years
Study Type INTERVENTIONAL
Interventions
Lev-g

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 30 participants in total. It began in 2024-04-12 with a primary completion date of 2027-02-28.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Health-related habits influences mental and physical health. Still, treatment of health-related habits, which can help to remedy health problems, is often not done at all or very superficially. Multiple guidelines emphasize the importance of prioritizing health-related habits, but there is a lack of implemented models. To solve this, the investigators have developed a transdiagnostic, interprofessional material intended for several care settings. The Lev-g intervention is intended for groups. There is also an individual version of Lev that has its on registration in Clinical Trails.

Eligibility Criteria

Inclusion Criteria: * both adults with and without disabilities recruited from different healthcare contexts. Exclusion Criteria: * Intellectual disability of the degree where the participant is not able to follow the protocol in Lev. * Insufficient command of the Swedish language/ unable to understand the content. * Severe psychiatric comorbidity that makes participation difficult (e.g. severe depression, severe suicidality, severe anxiety, ongoing psychosis, manic episode), other circumstances that could make participation hard (e.g. homelessness).

Contact & Investigator

Central Contact

Douglas Sjöwall, PhD

✉ douglas.sjowall@ki.se

📞 +46 (0)739568658

Principal Investigator

Douglas Sjöwall, PhD

PRINCIPAL INVESTIGATOR

Region Stockholm

Frequently Asked Questions

Who can join the NCT06404632 clinical trial?

This trial is open to participants of all sexes, aged 15 Years or older, up to 80 Years, studying Life Style. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06404632 currently recruiting?

Yes, NCT06404632 is actively recruiting participants. Contact the research team at douglas.sjowall@ki.se for enrollment information.

Where is the NCT06404632 trial being conducted?

This trial is being conducted at Stockholm, Sweden.

Who is sponsoring the NCT06404632 clinical trial?

NCT06404632 is sponsored by Region Stockholm. The principal investigator is Douglas Sjöwall, PhD at Region Stockholm. The trial plans to enroll 30 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology